Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.
Quick Facts
What This Study Found
rhTβ4 treatment was significantly more effective than ketoconazole in improving scalp conditions.
Key Numbers
How They Did This
The study involved a 4-week treatment of 71 SD patients with rhTβ4 gel or ketoconazole lotion, comparing clinical and physiological outcomes.
Why This Research Matters
Finding effective treatments for seborrheic dermatitis is crucial since current options are limited. This research highlights a new potential therapy that not only alleviates symptoms but also restores scalp microbiome balance.
What This Study Doesn't Tell Us
The study's sample size, while significant, may limit the generalizability of the findings, and long-term effects of rhTβ4 require further investigation.
Trust & Context
- Original Title:
- Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.
- Published In:
- Microbial biotechnology, 14(5), 2152-2163 (2021)
- Authors:
- Yu, Rui(3), Lin, Qingbin, Zhai, Yanfang, Mao, Yunyun, Li, Kai, Gao, Yuemei, Liu, Yanhong, Fu, Ling, Fang, Ting, Zhao, Mengsu, Guan, Lei, Hou, Lihua, Xu, Junjie, Chen, Wei
- Database ID:
- RPEP-05913
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05913APA
Yu, Rui; Lin, Qingbin; Zhai, Yanfang; Mao, Yunyun; Li, Kai; Gao, Yuemei; Liu, Yanhong; Fu, Ling; Fang, Ting; Zhao, Mengsu; Guan, Lei; Hou, Lihua; Xu, Junjie; Chen, Wei. (2021). Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.. Microbial biotechnology, 14(5), 2152-2163. https://doi.org/10.1111/1751-7915.13897
MLA
Yu, Rui, et al. "Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.." Microbial biotechnology, 2021. https://doi.org/10.1111/1751-7915.13897
RethinkPeptides
RethinkPeptides Research Database. "Recombinant human thymosin beta-4 (rhTβ4) improved scalp con..." RPEP-05913. Retrieved from https://rethinkpeptides.com/research/yu-2021-recombinant-human-thymosin-beta4
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.